Equillium, Inc.
Equillium develops therapies for severe autoimmune and inflammatory disorders.
DEF 14AAug 24Latest SEC filing, period to Sep 17
Aug 13Latest story
August 2026
Sign inSign inEquillium develops therapies for severe autoimmune and inflammatory disorders.